Vyv Announces Groundbreaking Inactivation And Killing Of Viruses With Its UV-free Antimicrobial Light Technology
Vyv Antimicrobial LED Technology (405nm) -- a Visible Light that Kills* Bacteria, Mold, Fungi and Yeast on Surfaces -- Now Shown to also Inactivate and Kill* Viruses
Partnerships and/or Investors Include Broan-NuTone, Citi, Delta Air Lines, Dorel Juvenile, Eastern Tabletop, Middleby Corporation, NJ Transit, Brilli, and the Healthcare Association of New York State (HANYS) Among Many Others
LATHAM, N.Y., May 12, 2021 /PRNewswire/ -- Vyv, a female founded and led health-tech industry leader and pioneer of antimicrobial LED technology, announces the recent independent test results confirming efficacy of its antimicrobial light technology (405nm) for killing* viruses. Numerous studies have proven the effectiveness of Vyv's visible light against bacteria, mold, fungi, and yeast. This recent study has confirmed, through an independent third-party lab, Vyv's antimicrobial LED products are also effective against non-enveloped viruses, which are the most difficult class of virus to kill*.
"The implications of this are vast because unlike harmful UV-C light, Vyv's patented technology can be used continuously and without restriction 24/7 around people, animals and plants. The recent findings of enhanced efficacy against viruses greatly expands the antimicrobial impact delivered to spaces currently protected with Vyv technology, as well as in new spaces," said Vyv CEO and co-founder Colleen Costello. "With our overhead LED products, Vyv is already lighting offices, schools and school buses, athletic centers, factories and hospitals. We're also embedding the same technology in many challenging spaces, including behind elevator buttons, inside consumer products such as humidifiers and bathroom fans, and in airplanes, trains and public buses."
Additionally, a recent separate third-party study also demonstrated efficacy results using ranges of light in the 400-420nm range on inactivating enveloped viruses. With Vyv's commitment to ongoing research and development advancements of a myriad of new products for healthier spaces, the company will continue to expand its virus testing in the coming months.
Global Industry Leaders Choose Vyv
Vyv has announced several high-profile business partnerships and investments with industry front-runners over the past six months. While the COVID-19 global pandemic continues to impact day-to-day life around the world, Vyv has joined forces and expanded development projects with Middleby Corporation, Citi, NJ Transit, Delta Air Lines, Broan-NuTone, Dorel Juvenile and Brilli, among several other well-respected brands. Most recently, Vyv announced a partnership with the Healthcare Association of New York State (HANYS), which is working to advance new approaches to infection control and prevention by dosing interior environments continuously with antimicrobial light to stop and kill* viruses, bacteria, fungi, mold and other organisms.
"Our partners have long understood the threats to global health and wellness. Many of these companies began engineering new solutions with Vyv's antimicrobial light long before the current pandemic. We've been on a path together to bring a new class of continuous microbial protection to address the world's ever-evolving microbial challenges," said Costello.
For further information, an expanded release, FAQ and images can be found here.
ABOUT VYV
Vyv, a female founded and managed health-tech company, is the creator of a new kind of continuous cleaning protection using visible light.Vyv, formerly Vital Vio, offers proprietary UV-free antimicrobial LED technology that creates environments inhospitable to the growth of viruses, bacteria, fungi, yeast, mold, and mildew. Unlike UV-C light, Vyv meets international standards for continual and unlimited use around people in homes, public places and across industries. As antimicrobial overhead lighting, Vyv can be found in homes, factories, offices, healthcare facilities, transportation and hospitality, and many other places.Vyv technology is also embedded within commercial and consumer products and applications. For more information, visit www.vyv.tech.
*Testing on a non-enveloped virus (MS2 bacteriophage) showed a 99.985% reduction in controlled laboratory testing in 6 hours on hard surfaces. MRSA and E. coli showed 90%+ reduction in controlled laboratory testing in 24 hours on hard surfaces. Results may vary depending on the amount of light that is reaching the surfaces in the space where the product is installed and the length of time of exposure. Use of Vyv antimicrobial light is not intended to replace manual cleaning.
---Vyv--
Contact:
Robin Shallow
Robin Communications
[email protected]
914.841.5572
SOURCE Vyv
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article